Respiratory Medications and Devices Update 2/15
|
|
- Imogen Higgins
- 5 years ago
- Views:
Transcription
1 Respiratory Medications and Devices Update 2/15 Dewey Hahlbohm, PA-C, AE-C Wendy Brown, Pharm.D., MPAS, PA-C, AE-C Objectives! Review mechanism of action for asthma pharmacologic agents! Describe key patient educational points for each! Compare and contrast various aerosol delivery devices including proper technique and limitations of device! Outline care and cleaning of devices
2 Pharmacotherapy! Antiinflammatory (controller/maintenance) versus bronchodilators (rescue/reliever) meds! Educate pts,! Role of medications! Role of monitoring! Role of treatment plans Long-term control medications! EPR-3 recommends long-term control medications be taken on a daily basis for treatment of persistent asthma! Inhaled corticosteroids (ICS)! Inhaled long-acting bronchodilators (LABA)! Leukotriene modifiers (Singulair)! Theophylline! Immunomodulators
3 Inhaled corticosteroids (ICS)! Most potent and consistently effective long-term control medication for treatment of asthma! Work on Airway inflammation through a variety of mechanisms! Effects: Decrease severity of symptoms, improve control and QOL, improve peak flow and spirometry, prevent exacerbations and decrease systemic corticosteroid use, ED visits, hospitalization and death Benefits of ICS! Increase number of!2- adrenergic receptors and improve the receptor responsiveness to!2- adrenergic stimulation?! Reduce mucous production and hypersecretion! Reduce bronchial hyperresponsiveness! Reduce airway edema and exudation
4 ICS: Local Adverse Effects! Oral candidiasis (thrush)! 45-58% of patients have + cultures (clinical thrush 0-34%)! Not as common with lower doses (5%)! Dysphonia! 5-50% of patients! Reflex cough and bronchospasm ICS: Systemic Adverse Effects! Linear growth:! Low-med dose ICS may have potential to decrease growth velocity in children! Effects are small and may be reversible! Studies show improved asthma outcomes in children! Expert Panel statements:! Risk is well balanced by benefits! Effects may be dose dependent! Poorly controlled asthma may delay growth in children! Effect typically occurs in first several months! Growth should be monitored
5 Generic Brand Dose/actuation notes Fluticasone Flovent 44, 110, 220 mcg 100, 250, 500 mcg HFA MDI Discus Triamcinolone acetonide Azmacort 100 mcg MDI with built in spacer Beclomethasone dipropionate QVAR 40 mcg 80 mcg HFA MDI Flunisolide Aerobid 250 mcg HFA MDI Budesonide Nebulizer suspension Pulmicort 200 mcg 0.25, 05 mg DPI, Turbuhaler Only available product for neb Mometasone furoate Azmanex twisthaler 110 mcg 220 mcg Breath-activated Once daily dosing Ciclesonide Alvesco 80 mcg, 160mcg, MDI, once daily dosing Dosing of ICS Ciclesonide Inhaled 80, 160 mcg/puff NA NA 320mcg NA NA > mcg NA NA >640mcg Adapted from: _asthma_guidelines.pdf
6 Combo Products Product Dosage Form Dose Fluticasone/ Salmeterol (Advair ) DPI: 100/50; 250/50; 500/50 HFA: 45/21; 115/21; 230/21 1 blister q 12 hours 2 inhalations q 12 hours Discus approved for kids >4 HFA approved for kids > 12 Budesonide/ Formoterol (Symbicort ) HFA: 80/4.5; 160/4.5 Two inhalations twice daily Approved for kids >12 Mometasone/ Formoterol (Dulera ) HFA: 100/5; 200/5 Two inhalations twice daily Approved for kids >12
7 Inhaled Corticosteroids Teach patient: About delay of onset Importance of taking every day Proper technique Use spacer for MDI RINSE and SPIT after each use Decrease oral thrush, dysphonia When to change canister Fear of steroids is common/need to provide accurate counseling/education to pts Leukotriene Modifiers Work on arachadonic acid cascade! Block leukotriene D4 (potent vasoconstrictor)! D4 at least 1000 times more potent than histamine! Leukotrients are inflammatory mediators that mediate airway obstruction, hyperresponsiveness and inflammation
8 Leukotriene Modifiers Dosage Form Adult dose Child Dose Comment Montelukast Singulair 4,5 mg chewtabs 10 mg tab 10 mg qhs Age: 2-5 y.o 4 mg qhs Age: 6-14 y.o. 5 mg qhs Age: >14 y.o. 10 mg qhs Has captured nearly all of the market for leukotriene modifiers Zafirlukast Accolate Zileuton Zyflo 10, 20 mg tab 20 mg bid Age: mg bid 300, 600 mg tab 2400 mg qday qid Has not been studied in kids <12 y.o Take 1 hr before/2hr after meals Monitor LFTs Monitor LFTs Long-Acting Bronchodialators (Beta 2 agonists)! EPR-3: Preferred adjunctive treatment to ICS for longterm control for step 3 in adults and children >12; steps 4 and 5 for kids 5-11 y.o. for long-term control of symptoms! Not recommended as monotherapy! No anti-inflammatory properties! Not recommended to treat acute symptoms
9 Long-Acting Bronchodilators (Beta 2 agonists)! MOA: relax bronchial smooth muscle by stimulating B2 receptors! B2 receptors found throughout respiratory tract! Duration of action: 12 hours not to be used more than twice daily LABA Indications: adjunctive therapy for moderate-severe persistent asthma Should NOT be used for EIB Products: Formoterol (Foradil ) 5 minute onset Salmeterol (Serevent ) 30 minute onset ADRs: headache, palpitations, tremor, nausea and vomiting
10 Long-Acting Beta-2 agonists: Therapeutic Issues: SMART Trial (Serevent Multi-center Asthma Research Trial) servent.htm! Compared to placebo: Serevent MAY be associated with increased risk of respiratory-related deaths/resp.- related life-threatening experiences! More prominent in African-Americans! Steroids under-utilized in SMART trial! LABAs should never be used as monotherapy
11 Combo products Product Dosage Form Dose Fluticasone/ Salmeterol (Advair ) DPI: 100/50; 250/50; 500/50 HFA: 45/21; 115/21; 230/21 1 blister q 12 hours 2 inhalations q 12 hours Discus approved for kids >4 HFA approved for kids > 12 Budesonide/ Formoterol (Symbicort ) HFA: 80/4.5; 160/4.5 Two inhalations twice daily Approved for kids >12 Mometasone/ Formoterol (Dulera ) HFA: 100/5; 200/5 Two inhalations twice daily Approved for kids >12
12 Combination Therapy
13 Omalizumab (Xolair )! EPR-3: recommended for step 5 and 6 care in patients who have allergies and who are inadequately controlled by high-dose ICS and LABA! Recombinant Anti-IgE monoclonal antibody! MOA: binds free IgE and IgE mast cells which leads to decrease in the release of mediators in response to allergen exposure! Approved in ages >12 y.o. with allergic asthma! Subcutaneous injection q 2-4 wks depending on baseline IgE levels and pts wt! Anaphylaxis has occurred: administered under medical supervision Anticholinergics! Limited role in asthma/first line in COPD! MOA: Inhibits muscarinic cholinergic receptors! Bronchodilation, reduces intrinsic vagal tone, may reduce mucous gland secretions! Adverse Effects: Dry mouth! Do not block EIB
14 Anticholinergics Long Acting Muscurinic Antagonists (LAMAS)! Tiotropium (Spiriva )! Convenient qday dosing via handihaler! Respimat formulation just released in 2015! Peak effect in 3 hours, durations 24 hours! Aclidinium (Tudorza)! Breath-actuated DPI: BID dosing! Duration 12 hours Tiotropium (Spiriva )! Long acting inhaled anticholinergic indicated for COPD. No role in asthma treatment
15 (Aclidinium bromide)tudorza! Long acting anticholinergic: Not indicated for asthma Anticholinergic Short acting Muscurinic Antagonists (SAMA)! Ipratropium bromide (Atrovent ):! Used with short-acting B2 agonist in multiple doses in moderate to severe asthma exacerbations in the emergency department! Combination product (albuterol/ipratropium-atrovent ) off of the market! Combivent respimat new product to replace atrovent! Peak affect hours, duration 4-6 hours
16 Combivent Respimat Quick-relief medicine! Prompt reversal of bronchoconstiction and accompanying symptoms (cough, chest tightness, wheeze, etc)! Short-acting B2-agonists! Anticholinergics! Systemic corticosteroids! Used for exacerbations
17 Short-acting B2-agonists! Smooth muscle relaxation! Rapid-onset of action: min! Duration of action: 4-6 hours! Use q 4 hours PRN (routine dosing discouraged)! May use min before exercise to prevent symptoms! Should always be available to patient Beta-2 Agonists Potential Adverse effects of both LABA and SABA Frequency and severity of ADRs directly related to dose and dosing frequency For typical short-acting, inhaled beta-2 agonists Frequency 1-5% Typical ADR s Headache/dizziness/vertigo Palpitations Tremor Nausea/vomiting ADRs with overuse: Hypokalemia Prolonged QTC interval
18 Short-acting B2-Agonists: Warning Signals! Needing more than every 4 hours! Needing every 4 hours all day long! Not responding to treatment within 15 min! Control: needing quick-relief less than twice weekly Short Acting B2 Agonist Albuterol HFA MDI (Pro-Air, Proventil, Ventolin) Also available as solution for nebulizer Levalbuterol MDI (Xopenex) Also available as solution for nebulizer
19 Inhaled Medication! Advantages! Rapid Onset of Action! Low incidence of systemic side effects! Success of inhaled medication dependent on:! Medication deposition! Particle size (2-5 microns desirable)! Inhalation mode! Patient features
20 Optimum inspiratory flow! Delivery to lungs is dependent on inspiratory airflow and medication device resistance! Inspiratory flow requirements may vary between devices Optimum inspiratory flow! Device Optimum Inspiratory Flow! Diskus L/min! Flexhaler L/min! Autohaler L/min! MDI L/min! Aerolizer L/min! Twisthaler L/min! Handihaler L/min
21 Metered Dose Inhaler! Teach closed mouth technique! 10-30% of the dose from the MDI delivered to lungs, 80% is swallowed! Problems:! Techniques! Hand lung coordination! Too brief breath hold! Inspiratrory flow too rapid! Insufficient canister shaking! Spraying in mouth breathing through the nose Metered Dose Inhaler! Technique:! Shake 6-10 times! Tilt head back slightly and breathe out slowly to empty lungs! Position the inhaler in mouth, between teeth with lips around the mouthpiece! Press down and slowly breath in for 3-5 seconds! Hold breath 10 seconds! Wait 1 minute before another puff
22 Factors affecting Dose Uniformity With Metered Dose Inhalers! Factors affecting Dose uniformity with MDI! Loss of Prime! Problem: After period of no use, first dose may be reduced or absent! Cause: Propellant drained from metering chamber! Loss of Dose! Problem: Dose diminishes, but is unnoticed because propellent remains the same! Cause: Active ingredient creams or settles! Tailing off! Problem: Erratic drug delivery after labeled number of doses! Cause: Metering chamber fills with vapor rather than propellent Education for dose uniformity! When to prime! Clean device! Remove canister: rinse in warm water! Clean at least once/week and as often as daily White stuff around the mouth piece can slow delivery! Teach patient to know when inhaler is gone: either tick method(count number of puffs used(easier to do with maintenance meds), or check dose counter
23 Spacers! Enhance aerosol delivery! Decrease need for coordination! Decrease systemic side effects! Reduce deposition in the oral cavity! Required for corticosteroids (decrease incidence of local side effects) Dry Powder inhalers for asthma! Diskus (Serevent, Flovent, Advair) multidose discrete dose! Flexhaler (Pulmicort) -- multidose reservoir! Twisthaler (Asmanex) multidose reservoir! Aerolizer (Foradil) single dose discrete dose
24 Dry Powder Inhalers! Fast deep breath as opposed to slow deep breath with MDI! General Care:! Keep dry at room temp! Never put in water! Wipe mouthpiece with tissue to clean! Never shake after dose is loaded! Never breath in to device Dry Powder Inhaler! Advantages:! No propellants! Improved Airway deposition! Eliminated need for spacer! Easy to teach and learn! Dose counters are included! Disadvantages:! Ability to be affected by humid air! No quick relief devices! Different devices require different flowrates technique isn t standardized
25 Diskus (Advair, Flovent)! Diskus DPI:! Mulitdose (60 doses)! Delivers about 90% of labeled dose at wide range of flow rates! Desirable for pts who have fluctuating flow rates with variation of ds.! Counter! Advantage: if you forget to put lever back you meet resistance! Use: click, click, breath in strong, steady and as deeply as possible, close to reset
26 Pulmicort Flexhaler! Multidose: 180 mcg 120 doses; 90 mcg 60 doses! More resistance to inhalation and requires more forceful inspiratory flow rates for consistent dosing! Variability of doses at different flow rates is higher than other devices! Dose indicator below mouthpiece red 20 doses! Priming: done with a new device! Remove Cover! Twist brown grip on bottom fully to the right then back to the left! You will hear a click, Repeat Pulmicort flexhaler! Using:! Remove cover! Hold upright! Twist brown grip fully to left then right click! Place in mouth! Breath in as quickly and deeply as possible! Hold 10 seconds! Replace cover twist to close
27 Asmanex Twisthaler! Multi-dose DPI. Contains 30,60, or 120 doses.! Use:! Open: hold the inhaler upright with the base on the bottom! Grip the base and twist the cap counterclockwise while keeping the inhaler in an upright position! As the cap is lifted off the dose counter counts down by one! Inhale dose: exhale fully, firmly close lips around the mouthpiece and take a fast, deep breath while holding the mouthpiece in a horizontal position,! Remove the inhaler from your mouth and hold breath for 10 seconds! Replace the cap and twist it clockwise until it clicks(the cap must be fully closed to load the next dose! Check to make sure that the arrow is lined up with the dose counter Asmanex Twisthaler
28 Foradil Aerolizer! Use! Dose placed into device before using! Capsule in foil! Pierce capsule! Never breath into mouthpiece! Whirring noise when inhaling should be heard! Sweet taste! Always discard empty capsule! Breath in rapidly steadily and completely Nebulizers! Advantages! Coordination of inspiration and treatment not required! use in infants, children, elderly, patient preference: allows slower, relaxed breathing during asthma flare, use for acute exacerbations! Disadvantages:! Cost and care issues! Length of treatment! Portability
29 Nebulizers! In general we should encourage patients to use MDI/DPI: can get same amount of medication with proper technique and much more convenient! Blow by technique used when mask intolerable. Directs aerosol towards nose and mouth with reservoir tube. NO DATA behind this.! Better to administer with close fit mask when child is asleep Nebulizers! Crying: completely prevents lower airway deposition in distressed child! "Kids <5 should use close fitting mask for nebs! Pulmicort respules should always be given with sealed mask to prevent getting in eyes, wipe mouth after use! Mouthpiece can start to be used around the age of 5! Pulmicort is the only ICS for nebulizer! "Dead volume: give neb until it sputters then tap and when it sputters no more will come out. The amount left is referred to as the dead volume This may be up to 1 ml depending on the neb
30 Nebulizers! Disposable Nebulizer! Changed every 2 weeks with regular daily use! Wash daily with mild detergent! Rinse well in running water and air dry completely! Disinfect regularly 1:3 dilution of white vinegar and water! Every 3 rd day! Soak 20 min rinse well air dry! Reusable Nebulizer:! Cleaned and reused for up to 6 months! Some dishwasher safe! Store in plastic ziplock bag once dry! Neb cup rinsed after each treatment to eliminate leftover meds Only in Montana
31 Questions? Thanks for being here, enjoy the rest of your Asthma Educator Conference
10/18/2012. Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C
Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C Daily: Long-Term Control Corticosteroids (inhaled and systemic) Long-acting beta 2 -agonists (Serevent, Foradil) Methylxanthines
More informationThe Medical Letter. on Drugs and Therapeutics
The Medical Letter publications are protected by US and international copyright laws. Forwarding, copying or any other distribution of this material is strictly prohibited. For further information call:
More informationQuestion I was one of the first dry power devices available in the US Flovent, Serevent and Advair are all available in this device
What Device am I Class Side Effects History Potpourri Monitoring Tools 10 10 10 10 10 20 20 20 20 20 30 30 30 30 30 40 40 40 40 40 50 50 50 50 50 WHAT KIND OF DEVICE AM I? I was one of the first dry power
More informationCOPD Medicine. No one ever showed me how to use this. Wendy Happel; RRT, COPD Educator Krystal Fedoris; RRT-NPS, BA, COPD Educator
Medicine. No one ever showed me how to use this. Wendy Happel; RRT, Educator Krystal Fedoris; RRT-NPS, BA, Educator 1 Taking prescriptions correctly Taking prescriptions can be a challenge Busy schedules
More informationBREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate)
Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) BREEZHALER Please date initial after you have directly observed
More informationHow to Use Inhaled Medications for Asthma and COPD
How to Use Inhaled Medications for Asthma and COPD This information is not intended to diagnose health problems or to take the place of medical advice or care you receive from your physician or other health
More informationDiagnosis and Management of Asthma
Supporting Evidence: Diagnosis and Management of Asthma The subdivision of this section is: Appendix B Tables Copyright 2016 by 1 Eleventh Edition/December 2016 Appendix B Asthma Summary Tables Class:
More informationFoundations of Pharmacology
Pharmacologic Management of Asthma Objectives: 1. Review the physiological basis for asthma therapy 2. Discuss the differences between SABA and LABA 3. Discuss the role of inhaled and oral systemic corticosteroids
More informationBREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate)
Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) BREEZHALER Please date initial after you have directly observed
More informationInhaled bronchodilators relax constricted airways and treat the noisy part of asthma: coughing, wheezing, choking and shortness of breath.
Inhaled bronchodilators relax constricted airways and treat the noisy part of asthma: coughing, wheezing, choking and shortness of breath. AccuNeb inhalation 0.021% solution: 0.63mg/3mL 3-4 times solution
More informationFerris State University College of Pharmacy MPA CE Symposium 2016 Paul Thill, PharmD, BCPS
Ferris State University College of Pharmacy MPA CE Symposium 2016 Paul Thill, PharmD, BCPS Objectives Categorize the new asthma and COPD inhalers in to existing or newly created categories Discuss the
More informationBREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate)
Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) BREEZHALER Please date initial after you have directly observed
More informationA Visual Approach to Simplifying Respiratory Drug Regimens
A Visual Approach to Simplifying Respiratory Drug Regimens Stephanie Cheng, PharmD, MPH, BCGP 3 Main Categories Inhaled Respiratory Drugs Binds to beta-2 receptors Relaxation of smooth muscles in the lung
More information12/18/2017. Disclosures. Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing
Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing Diana M. Sobieraj, PharmD, BCPS Assistant Professor University of Connecticut School
More informationCorrect Use of Inhaler Devices
PL Detail-Document #300206 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER February 2014 Correct Use of
More informationHow to Use Inhaled Medications
How to Use Inhaled Medications FOR ASTHMA AND COPD introduction Inhaled medications are an important part of controlling and treating asthma and chronic obstructive pulmonary disease (COPD). The medication
More informationAsthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing
Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing Diana M. Sobieraj, PharmD, BCPS Assistant Professor University of Connecticut School
More informationYour Inhaler Devices & You
1 Your Inhaler Devices & You COUNSEL ON THE APPROPRIATE USE OF A: METERED DOSE INHALER (MDI) DRY POWDER INHALER (DPI) DISCUSS THE APPROPRIATE USAGE OF A PEAK FLOW METER AND SPACER/HOLDING CHAMBER DEVICE
More informationAerosol Delivery Devices
Aerosol Delivery Devices Judy Bielenda LRRT Respiratory Therapy Clinical Specialist Pediatric Asthma Education Coordinator University of Michigan C.S. Mott Children s and Von Voigtlander Women s Hospital
More informationMANAGING ASTHMA. Nancy Davis, RRT, AE-C
MANAGING ASTHMA Nancy Davis, RRT, AE-C What is asthma? Asthma is a chronic respiratory disease characterized by episodes or attacks of inflammation and narrowing of small airways in response to asthma
More informationA Visual Approach to Simplifying Respiratory Drug Regimens
Adverse Effects of Inhaled Medications A Visual Approach to Simplifying Respiratory Drug Regimens Stephanie Cheng, PharmD, MPH, BCGP June 28, 2017 Drug Category Beta 2 agonists antagonists Adverse Effects
More informationA Visual Approach to Simplifying Respiratory Drug Regimens
A Visual Approach to Simplifying Respiratory Drug Regimens Stephanie Cheng, PharmD, MPH, BCGP October 23, 2017 Learning Objectives Be able to list at least 3 major adverse effects of inhaled medications
More informationWhat You Need to Know about Metered-Dose Inhalers and the HFA Propellant
What You Need to Know about Metered- Inhalers and the HFA Propellant There are a number ways to deliver inhaled medication. They include: Metered-dose inhaler () Metered-dose inhaler with spacer/holding
More informationHow can I benefit most from my COPD medications?
Fact Sheet: COPD Medications and Delivery Devices How can I benefit most from my COPD medications? COPD medications can improve your symptoms. By taking the right medication at the right time, you can
More informationPocket Guide to Inhaler Technique A Step-By-Step Guide for Healthcare Professionals
Pocket Guide to Inhaler Technique A Step-By-Step Guide for Healthcare Professionals Endorsed by NHSGGC Respiratory Managed Clinical Network; June 2016 Designed by Medical Illustration Services Contents
More informationMDI Bonanza. Dwayne Griffin, DO
MDI Bonanza Dwayne Griffin, DO Bonanza 3. A MDI costing $200 - $500 per month SISYPHUS MDI Griffin Mountain Evolution of Deliver Systems for COPD in the US 2003 2009 2011 2013 2004 2012 2014 Prescribing
More informationAsthma medications: Know your options - MayoClinic.com. Asthma medications: Know your options
MayoClinic.com reprints This single copy is for your personal, noncommercial use only. For permission to reprint multiple copies or to order presentation-ready copies for distribution, use the reprints
More informationMedications for Managing COPD in Hospice Patients. Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources
Medications for Managing COPD in Hospice Patients Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources Goal of medications in COPD Decrease symptoms and/or complications Reduce frequency
More informationAppendix M: Device Technique
Nursing Care of Dyspnea: The 6th Vital Sign in Individuals with Chronic Obstructive Pulmonary Disease (COPD) Appendix M: Device Technique Medications: Inhalation Devices Medications come in many forms.
More informationDrugs that Affect the Respiratory System BROOKE BENTLEY, PHD, APRN
Drugs that Affect the Respiratory System BROOKE BENTLEY, PHD, APRN Goals of Therapy Asthma Prevent symptoms COPD Reduce COPD symptoms Decrease use of SABAs Maintain normal pulm function & prevent loss
More informationBreezhaler. Open to see clear capsule. How do I use my Breezhaler? Care of my Breezhaler
Breezhaler 3 Pull cap off Press buttons once and release Breathe in rapidly and steadily. Hold. Open. Place capsule in chamber. Close (click). Breathe out 4 Open to see clear capsule. If not all clear
More informationMedications Affecting The Respiratory System
Medications Affecting The Respiratory System Overview Asthma is a chronic inflammatory disorder of the airways. It is an intermittent and reversible airflow obstruction that affects the bronchioles. The
More informationTRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder
TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific
More informationReference Guide for Caring for Pediatric Patients with Asthma
Reference Guide for Caring for Pediatric Patients with Asthma Co-Chair: Nancy Cantey Banasiak, DNP, PPCNP-BC, APRN Co-Chair: Deborah Hickman, DNP, APRN-CNP, CPNP-PC, NNP-BC Asthma and Allergy SIG Members
More informationKey features and changes to these four components of asthma care include:
Guidelines for the Diagnosis and Management of Asthma in Adults Clinical Practice Guideline MedStar Health These guidelines are provided to assist physicians and other clinicians in making decisions regarding
More informationCommon Inhaled Asthma Medications Dose Comparison and Tips for Use
Detail-Document #210303 This Detail-Document accompanies the related article published in PHARMACIST S LETTER / PRESCRIBER S LETTER March 2005 ~ Volume 21 ~ Number 210303 Common Inhaled Asthma Medications
More informationAsthma. Definition. Symptoms
Asthma Definition Asthma is a condition in which your airways narrow and swell and produce extra mucus. This can make breathing difficult and trigger coughing, wheezing and shortness of breath. For some
More informationNancy Davis, RRT, AE-C
Nancy Davis, RRT, AE-C Asthma Statistics 25.6 million Americans diagnosed with asthma 6.8 million are children 10.5 million missed school days per year 14.2 lost work days for adults Approximately 10%
More informationAppendix E: Device Technique
Adult Asthma Care Guidelines for Nurses: Promoting Control of Asthma Appendix E: Device Technique Medications: Inhalation Devices Adapted with permission from The Lung Association: www.lung.ca/asthma/manage/devices.html
More informationNEBULIZERS, METERED DOSE INHALERS, AND DRY POWDER INHALERS
NEBULIZERS, METERED DOSE INHALERS, AND DRY POWDER INHALERS Douglas S. Gardenhire, Ed.D, RRT-NPS MODULE 1 Manipulate Small Volume Nebulizers by Order or Protocol 1 Objectives for Module 1 At the end of
More informationRespiratory Health. Asthma and COPD
Respiratory Health Asthma and COPD Definition of asthma Working definition by AAH 2014: Chronic lung disease Can be controlled not cured Large variation in lung function Large variation in respiratory
More informationUsing Inhaled Corticosteroids as Needed for Asthma: giving patients relief or leaving them breathless?
Using Inhaled Corticosteroids as Needed for Asthma: giving patients relief or leaving them breathless? Lindsay Thomas, Pharm.D. PGY2 Ambulatory Care Resident Department of Pharmacotherapy and Pharmacy
More informationMEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 07/05/18 SECTION: DRUGS LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:
CINQAIR (reslizumab) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
More informationCOPD RESOURCE PACK Section 5. Drug Treatment & Inhalers in Stable COPD
COPD RESOURCE PACK Section 5 Drug Treatment & Inhalers in Stable COPD In this section: 1. Links to Fife Formulary 2. Pharmacological Management of Stable COPD 3. How to use a Metered Dose Inhaler 4. How
More informationINHALERS for COPD INTRODUCTION. Types of inhalers. Inhaler technique. MDIs for COPD WET AEROSOLS. Dr Christopher Worsnop
INHALERS for COPD Dr Christopher Worsnop Department of Respiratory Medicine Austin Hospital INTRODUCTION Most drugs for COPD are given via inhalers. This reduces the dose that needs to be given and delivers
More informationUsing an Inhaler and Nebulizer
Using an Inhaler and Nebulizer Introduction An inhaler is a handheld device that is used to deliver medication directly to your airways. A nebulizer is an electric or battery powered machine that turns
More informationprimer on inhalers and nebulizers
CREDIT: 2.0 Continuing Education EARN CE CREDIT FOR THIS ACTIVITY AT WWW.DRUGTOPICS.COM AN ONGOING CE PROGRAM OF THE UNIVERSITY OF CONNECTICUT SCHOOL OF PHARMACY AND DRUG TOPICS educational objectives
More informationGuide to Inhaled Treatment Choices
Guide to Inhaled Treatment Choices Note: this is guidance only, it is important to consider which device is best suited to the patient. This may NOT be the first line choice (but should be on the joint
More informationGuide to Inhaled Treatment Choices
Guide to Inhaled Treatment Choices Note: this is guidance only, it is important to consider which device is best suited to the patient. This may NOT be the first line choice (but should be on the joint
More informationEnd Stage COPD Guidance Document
End Stage COPD Guidance Document Suggested Guidelines for the Determination of Hospice Eligibility A patient with severe chronic pulmonary disease that meets the following criteria may be eligible for
More information2008 IPAC-RS Conference Doing the Right Thing Science, Quality and Patient Focus
2008 IPAC-RS Conference Doing the Right Thing Science, Quality and Patient Focus Patient Perspective Alpha-1 1 Foundation John W. Walsh Patient Focus Personal perspective Challenges and lessons Importance
More informationAllergies and Asthma 5/21/2013. Objectives. Allergic Rhinitis (AR): Risk Factor for ASTHMA. Rhinitis and Asthma
Allergies and Asthma Presented By: Dr. Fadwa Gillanders, Pharm.D Clinical Pharmacy Specialist May 2013 Objectives Understand the relationship between asthma and allergic rhinitis Understand what is going
More informationFASENRA (benralizumab)
FASENRA (benralizumab) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
More informationMetered Dose Inhaler (MDI)
Metered Dose Inhaler (MDI) If the inhaler has not been used before, a test dose should be fired into the air to prime the system. 1. Remove cap. 2. Shake well. 3. Breathe out fully. 4. Holding inhaler
More informationDisclosure. Case. Objectives. Case Continued. Inhalers. Asthma: A GINA Update to the NAEPP 2007 Guidelines 1/20/2015
Disclosure Asthma: A GINA Update to the NAEPP 2007 Guidelines Robert (RC) Hellinga, Pharm.D. PGY 1 Pharmacy Resident Wolfson Children s Hospital/Baptist Health I do not have a vested interest in or affiliation
More informationGMMMG Asthma Formulary Inhaler Options August 2017
Regular Preventer Beclometasone Beclometasone Beclometasone Brand name Qvar Easi-Breathe Clenil Modulite Easyhaler Device MDI MDI DPI Strengths 50 microgram 100 microgram 200 microgram Adult asthma 2 inhalations
More informationAsthma in Pregnancy. Asthma. Chronic Airway Inflammation. Objective Measures of Airflow. Peak exp. flow rate (PEFR)
Chronic Airway Inflammation Asthma in Pregnancy Robin Field, MD Maternal Fetal Medicine Kaiser Permanente San Francisco Asthma Chronic airway inflammation increased airway responsiveness to a variety of
More informationDrug Class Monograph
Drug Class Monograph Class: Inhaled Corticosteroids Drugs: Aerospan (flunisolide), Advair Diskus, Advair HFA (fluticasone/salmeterol), Alvesco (ciclesonide), Arnuity Ellipta (fluticasone furoate), Asmanex
More informationAsthma training. Mike Levin Division of Asthma and Allergy Red Cross Hospital
Asthma training Mike Levin Division of Asthma and Allergy Red Cross Hospital Introduction Physiology Diagnosis Severity Treatment Control Stage 3 of guidelines Acute asthma Drug delivery Conclusion Overview
More informationAsthma By Mayo Clinic staff
MayoClinic.com reprints This single copy is for your personal, noncommercial use only. For permission to reprint multiple copies or to order presentation-ready copies for distribution, use the reprints
More informationMEDICATION GUIDE. ADVAIR [ad vair] HFA 45/21 (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol
MEDICATION GUIDE ADVAIR [ad vair] HFA 45/21 (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol ADVAIR HFA 115/21 (fluticasone propionate 115 mcg and salmeterol 21 mcg) Inhalation
More informationASTHMA BEST PRACTICES FOR SCHOOL NURSES. School Nurses November 2015
ASTHMA BEST PRACTICES FOR SCHOOL NURSES School Nurses November 2015 1 BACKGROUND AND CURRENT STATS General definitions and explanations 2 Incidence of Asthma Centers for Disease Control (CDC) - 1 in 12
More informationAIRDUO RESPICLICK (fluticasone-salmeterol) aerosol DULERA (mometasone furoate and formoterol fumarate dihydrate) aerosol
DULERA (mometasone furoate and formoterol fumarate dihydrate) aerosol Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific
More informationInhalation devices, proper technique and cleaning
Preventing Your Symptoms and Taking Your Medications Inhalation devices, proper technique and cleaning Knowing how to use your medications properly is important because inhaled drugs are meant to get directly
More informationCOPD Update: Focus on Intensifying LABA, LAMA and ICS Therapy
Update: Focus on Intensifying LABA, LAMA and ICS Therapy B.C. Provincial Academic Detailing Service February 2017 Background In Canada, approximately 20 inhaled medications are approved to treat Chronic
More informationStaying Healthy. with Asthma. Illustrations by paulsharp.com
Staying Healthy with Asthma Illustrations by paulsharp.com Lungs & Asthma What is Asthma? Inflammation or swelling of airways that leads to: 1) Mucous production deep inside the airways. 2) Temporary difficulty
More informationDiagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma
Diagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma Magnitude of Asthma - India Delhi Childhood asthma: 10.9% Adults: 8% Other Cities 3 to 18% Chhabra SK et al Ann Allergy Asthma
More informationCARE AT HOME: ASTHMA. A guide for parents. childrensmn.org
CARE AT HOME: ASTHMA A guide for parents childrensmn.org Content Your child has asthma a chronic lung disease. To best control the symptoms of asthma, it is important that you learn all you can about asthma.
More informationPharmacist Objectives. Pulmonary Update. Outline. Technician Objectives. GOLD Guidelines. COPD Diagnosis 9/22/2017
Pharmacist Objectives Pulmonary Update Patty Marshik, PharmD Associate Professor University of New Mexico College of Pharmacy pmarshik@salud.unm.edu Discuss the new Global Initiative for Chronic Obstructive
More informationANTINEOPLASTIC DRUGS CHAPTER 21. Antineoplastic drugs - designed to treat malignancies, now also used to treat diseases with inflammatory component
ANTINEOPLASTIC DRUGS CHAPTER 21 Antineoplastic drugs - designed to treat malignancies, now also used to treat diseases with inflammatory component Tx of malignancies Antineoplastic drugs: methotrexate
More informationINHALATION TECHNIQUES FOR CHILDREN AND Adolescents Oslo University Hospital, RIKSHOSPITALET
INHALATION TECHNIQUES FOR CHILDREN AND Adolescents Oslo University Hospital, RIKSHOSPITALET DIVISION OF PAEDIATRIC AND ADOLESCENT MEDICINE (BARNEKLINIKKEN) VOKSENTOPPEN The information contained in this
More informationII: Moderate Worsening airflow limitations Dyspnea on exertion, cough, and sputum production; patient usually seeks medical
Table 3.1. Classification of COPD Severity Stage Pulmonary Function Test Findings Symptoms I: Mild Mild airflow limitations +/ Chronic cough and sputum production; patient unaware of abnormal FEV 1 80%
More informationRespiratory Care 2. Clinical Skills School of Medicine 2015/16
Respiratory Care 2 Clinical Skills School of Medicine 2015/16 Learning Objectives Identify the different types of inhalers and demonstrate the correct inhaler techniques for the different inhalers. Demonstrate
More informationFIGURE 17. USUAL DOSAGES FOR LONG-TERM CONTROL MEDICATIONS*
FIGURE 17. USUAL DOSAGES FOR LONG-TERM CONTROL MEDICATIONS* 0 4 Years Age and Adults Potential Adverse Effects Inhaled Corticosteroids (See Figure 18, Estimated Comparative Daily Dosages for ICSs. ) Oral
More informationAsthma COPD Update 2018
Asthma COPD Update 2018 Roger Hefflinger, Pharm.D. Clinical Associate Professor ISU COP Clinical Teaching Pharmacist Family Medicine Residency of Idaho In support of improving patient care, Idaho State
More informationCOPD Medications Coverage Summary Non-Insured Health Benefits Coverage SABA Bricanyl turbuhaler Yes Yes
COPD Medications Coverage Summary Drug Non-Insured Health Benefits Coverage SABA Bricanyl turbuhaler Yes Yes Ventolin MDI + generics Yes Yes Ventolin Diskus NO NO Yukon Pharmacare/Chronic Disease Program
More informationAerospan (flunisolide)
STRENGTH DOSAGE FORM ROUTE GPID 80mcg/actuation HFA aerosol inhaler w/ Inhaled 35718 8.9 g/canister adapter MANUFACTURER Meda Pharmaceuticals INDICATION Aerospan Inhalation Aerosol is indicated for the
More informationHome Management Plan. Cover Page
Home Management Plan Cover Page What is Asthma? Asthma is a chronic disease of the lungs caused by swelling and irritation in the lining of airways Tightness of the airway muscles Excess mucus in the airways
More informationreslizumab (Cinqair )
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
More informationAsthma Pharmacotherapy 2017: Stepwise Approach to Managing Asthma
Asthma Pharmacotherapy 2017: Stepwise Approach to Managing Asthma Webinar for Michigan Center for Clinical Systems Improvement (Mi-CCSI) Karen Meyerson, MSN, APRN, NP-C, AE-C Director, Commercial Care
More informationTaking Control of Asthma Through Proper Medication Selection and the Use of Asthma Action Plans Julie M. Koehler, Pharm.D., FCCP
Taking Control of Asthma Through Proper Medication Selection and the Use of Asthma Action Plans Julie M. Koehler, Pharm.D., FCCP Associate Dean for Clinical Education and External Affiliations & Professor
More informationbenralizumab (Fasenra )
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
More informationFirst to Market or 505 (b)2 CMC Considerations IPAC-RS/UF Orlando Inhalation Conference Orlando, Florida
First to Market or 505 (b)2 CMC Considerations IPAC-RS/UF Orlando Inhalation Conference Orlando, Florida Prasad Peri, Ph.D., Branch Chief, ONDQA, FDA March 19, 2014 1 Topics for discussion Introduction
More informationPATIENT INFORMATION. ADVAIR DISKUS [AD vair DISK us] (fluticasone propionate and salmeterol inhalation powder) for oral inhalation
PATIENT INFORMATION ADVAIR DISKUS [AD vair DISK us] (fluticasone propionate and salmeterol inhalation powder) for oral inhalation What is ADVAIR DISKUS? ADVAIR DISKUS combines the inhaled corticosteroid
More informationSTRIVERDI RESPIMAT (olodaterol hcl) aerosol
STRIVERDI RESPIMAT (olodaterol hcl) aerosol Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy
More informationUp in FLAMES: Stable Chronic Obstructive Pulmonary Disease (COPD) Management. Colleen Sakon, PharmD BCPS September 27, 2018
Up in FLAMES: Stable Chronic Obstructive Pulmonary Disease (COPD) Management Colleen Sakon, PharmD BCPS September 27, 2018 Disclosures I have no actual or potential conflicts of interest 2 Objectives Summarize
More informationNHS Northern, Eastern and Western Devon Clinical Commissioning Group NHS South Devon and Torbay Clinical Commissioning Group
NHS Northern, Eastern and Western Devon Clinical Commissioning Group NHS South Devon and Torbay Clinical Commissioning Group Inhaler technique and respiratory conditions Guidance Sheet 16 When diagnosed
More informationPosition within the Organisation
ASTHMA TREATMENT GUIDELINES Document Description Document Type Service Application Guidelines All healthcare professionals(hcps) caring for patients with asthma Version 4.0 Ratification date September
More informationAsthma Description. Asthma is a disease that affects the lungs defined as a chronic inflammatory disorder of the airways.
Asthma Asthma Description Asthma is a disease that affects the lungs defined as a chronic inflammatory disorder of the airways. Symptoms of asthma In susceptible individuals, this inflammation causes recurrent
More informationGMMMG COPD Formulary Inhaler Options October 2017
BNF 3.1.1 Adrenocepter agonists (SABA) Salbutamol Salbutamol Terbutaline Brand name Airsalb Ventolin Evohaler Bricanyl Turbohaler Device MDI MDI Dry powder Strengths 100 microgram 100 microgram 500 microgram
More informationDOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL
DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL I. Uniform Formulary Review Process Under 10 U.S.C. 1074g, as implemented by 32
More informationAsthma Education. The Keys to Asthma Prevention and Control. what to do when one s asthma is flared! Lucile Packard Children s Hospital.
Asthma Education Lucile Packa r d Children s H o spit al Created by Rachel Lawler RN, MSN, cpnp, AE-C, NPAT Pulmonary Pediatric Nurse Practitioner Lucile Packard Children s Hospital The Keys to Asthma
More informationInhaler Devices. Ask the patient/carer to demonstrate the technique and correct accordingly at every opportunity.
Inhaler Devices The most effective way of taking most asthma medicines is to inhale them so they get straight into the lungs. The best inhaler device is one that the patient can and will use. The correct
More informationInhaler technique reminder cards
Inhaler technique reminder cards Produced by the Medicines Optimisation Team NHS NEW Devon CCG For further information visit: www.newdevonccg.nhs.uk/information-for-patients/medicines-and-treatments/100073
More informationMANAGEMENT OF ASTHMA SPRING Presented by:
MEDS@Work MANAGEMENT OF ASTHMA SPRING 2013 Presented by: Lusia Fomuso PharmD candidate 2014 Olivia Sibailly PharmD candidate 2014 Kimberly Biedka PharmD candidate 2014 Dr. Donna Bartlett PharmD CGP RPh
More informationGINA. At-A-Glance Asthma Management Reference. for adults, adolescents and children 6 11 years. Updated 2017
GINA At-A-Glance Asthma Management Reference for adults, adolescents and children 6 11 years Updated 2017 This resource should be used in conjunction with the Global Strategy for Asthma Management and
More informationProvider Respiratory Inservice
Provider Respiratory Inservice 2 Welcome Opening Remarks We will cover: Definition of Asthma & COPD Evidence based guidelines for diagnosis, evaluation, and management of asthma Evidence based guidelines
More informationInhaled Corticosteroids Drug Class Prior Authorization Protocol
Inhaled Corticosteroids Drug Class Prior Authorization Protocol Line of Business: Medicaid P&T Approval Date: February 21, 2018 Effective Date: April 1, 2018 This policy has been developed through review
More informationLearning Objectives 4/26/2012. Review normal lung function and COPD pathophysiology Discuss pharmacological management
Marliese Gibson PharmD HospiScript, a Catalyst Rx Company May 16, 2012 Chronic Obstructive Pulmonary Disease Learning Objectives Review normal lung function and COPD pathophysiology Discuss pharmacological
More information